Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Adult lifetime alcohol consumption and invasive epithelial ovarian cancer risk in a population-based case-control study.
Higher levels of wine consumption were generally associated with risk reductions.
»
10/27/15
MAP Kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma.
Downstream analyses may identify melanoma patients that could benefit from targeted therapies with MEK and ERK inhibitors.
»
04/21/15
Racial and Ethnic Variations in Lung Cancer Incidence and Mortality: Results From the Women's Health Initiative.
Hispanic and Asian/Pacific Islander women had decreased risk of death
»
12/25/15
XBP1 silencing decreases glioma cell viability and glycolysis possibly by inhibiting HK2 expression.
XBP1s activation was involved in glioma glycolysis regulation.
»
07/28/15
An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.
The IL-33/ST2 signalling axis may have a protective role in colon carcinogenesis.
»
11/06/15
Survivin contributes to DNA repair by homologous recombination in breast cancer cells.
Survivin depletion triggers p53 activation and sensitizes cancer cells to of PARP inhibition.
»
11/26/15
Meta-analysis of the relationship between slow acetylation of N-acetyl transferase 2 and the risk of bladder cancer.
NAT2 slow acetylation state was associated with bladder cancer risk.
»
12/19/15
Digoxin therapy is not associated with improved survival in epithelial ovarian cancer: A SEER-Medicare database analysis.
Digoxin use during chemotherapy was not associated with improved OS outcomes.
»
09/27/15
An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.
The higher the tumour grade, the lower the expression of ST2L (P=0.026).
»
11/06/15
Progestin and breast cancer risk: a systematic review.
Progestin-only formulations do not increase the risk of breast cancer.
»
09/28/15
< Prev
Next >